Pharmacodynamics of in vivo nitrate action

American Journal of Cardiology

Volumn 81, Issue 1 A, 1998, Pages

  Fung, H L ^a   Booth, B P ^a   Bauer, J A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRATE;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERANCE; DRUG WITHDRAWAL; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MATHEMATICAL MODEL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION INHIBITION; TRANSDERMAL DRUG ADMINISTRATION; VASOCONSTRICTION; VASODILATATION;

EID: 0031939736     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00993-4     Document Type: Conference Paper

References (28)

1. M Packer What causes tolerance to nitroglycerin? The 100 year old mystery continues J Am Coll Cardiol 16 1990 932 935
2. HL Fung Solving the mystery of nitrate tolerance A new scent on the trail? (Editorial.) Circulation 88 1993 322 324
3. T Münzel H Sayegh BA Freeman MM Tarpey DG Harrison Evidence for enhanced vascular superoxide anion production in nitrate tolerance A novel mechanism underlying tolerance and cross-tolerance J Clin Invest 95 1995 187 194
4. T Münzel T Heitzer S Kurz DG Harrison C Luhman L Pape M Olschewski H Just Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease J Am Coll Cardiol 27 1996 297 303
5. T Münzel S Kurz S Rajagopalan M Thoenes WR Berrington JA Thompson BA Freeman DG Harrison Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase a new action for an old drug J Clin Invest 98 1996 1465 1470
6. AI Haj-Yehia LZ Benet Dissociation of tissue thiol content from nitroglycerin-induced cyclic-3′,5′-guanosine monophosphate and the state of tolerance in vivo experiments in rats J Pharmacol Exper Ther 273 1995 94 100
7. AI Haj-Yehia LZ Benet In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance J Pharmacol Exp Ther 278 1996 1296 1305
8. E Kowaluk K Hough HL Fung Effect of intermittent exposure and drug-free intervals on the in vitro vascular tolerance to nitroglycerin Life Sci 44 1989 1157 1163
9. H Gogia A Mehra S Parikh M Raman J Ajit-Uppal JV Johnson U Elkayam Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure J Am Coll Cardiol 26 1995 1575 1580
10. JD Parker AB Parker B Farrell JO Parker The effect of hydralazine on the development of tolerance to continuous nitroglycerin J Pharmacol Exp Ther 280 1997 866 875
11. DJ Stewart J Holtz E Bassenge Long-term nitroglycerin treatment effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs Circulation 75 1987 847 856
12. JA Bauer HL Fung Effects of chronic glyceryl trinitrate on left ventricular haemodynamics in a rat model of congestive heart failure demonstration of a simple animal model for the study of in vivo nitrate tolerance Cardiovasc Res 24 1990 198 203
13. JA Bauer HL Fung Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic rebound in experimental heart failure Circulation 84 1991 35 39
14. JA Bauer HL Fung Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure Pharmaceut Res 10 1993 1341 1345
15. JA Bauer HL Fung W Zheng YW Kwon M Gopalakrishnan DJ Triggle Continuous versus intermittent nitroglycerin administration in experimental heart failure vascular relaxation and radioligand binding to adrenoceptors and ion channels J Cardiovasc Pharmacol 22 1993 600 608
16. JA Bauer HL Fung Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure J Pharmacol Exper Ther 256 1991 249 254
17. JA Bauer HL Fung Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure Pharmaceut Res 11 1994 816 823
18. 2+ channels in experimental cardiac failure Am J Physiol 261 1991 H1979 H1987
19. H Selye E Bajusz S Grasso P Mendell Simple techniques for the surgical occlusion of coronary vessels in the rat Angiology 11 1960 398 407
20. T Münzel A Giaid S Kurz DJ Stewart DG Harrison Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance Proc Natl Acad Sci USA 92 1995 5244 5248
21. JA Bauer JP Balthasar H-L Fung Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure Pharm Res 14 1997 1140 1145
22. EF McNiff A Yacobi FM Young-Chang LH Golden A Goldfarb HL Fung Nitroglycerin pharmokinetics after intravenous infusion in normal subjects J Pharmaceut Sci 70 1981 1054 1058
23. MT Olivari PF Carlyle TB Levine JN Cohn Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure J Am Coll Cardiol 2 1983 872 878
24. M Ferratini S Pirelli P Merlini P Silva G Pollavini Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina a comparison with a continuous schedule Eur Heart J 10 1989 998 1002
25. H DeMots SP Glasser Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina J Am Coll Cardiol 13 1989 786 793
26. BP Booth S Jacob JA Bauer H-L Fung Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats J Cardiovasc Pharmacol 28 1996 432 438
27. D Hebert J-X Xiang J Y-T Lam Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance Circulation 95 1997 1308 1313
28. BP Booth JD Nolan H-L Fung Nitroglycerin-inhibited whole blood aggregation is partially mediated by calcitonin gene-related peptide—a neurogenic mechanism Br J Pharmacol 122 1997 577 583